State Street’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30,494
| Closed | -$48K | – | 4717 |
|
|
2021
Q2 | $48K | Sell |
30,494
-624,899
| -95% | -$984K | ﹤0.01% | 4431 |
|
|
2021
Q1 | $1.46M | Buy |
655,393
+50,378
| +8% | +$112K | ﹤0.01% | 3542 |
|
|
2020
Q4 | $1.5M | Buy |
605,015
+108,894
| +22% | +$270K | ﹤0.01% | 3466 |
|
|
2020
Q3 | $1.22M | Buy |
496,121
+74,138
| +18% | +$182K | ﹤0.01% | 3381 |
|
|
2020
Q2 | $1.5M | Buy |
+421,983
| New | +$1.5M | ﹤0.01% | 3292 |
|
|
2019
Q3 | – | Sell |
-23,677
| Closed | -$34K | – | 3826 |
|
|
2019
Q2 | $34K | Sell |
23,677
-461,907
| -95% | -$663K | ﹤0.01% | 3748 |
|
|
2019
Q1 | $957K | Buy |
485,584
+18,837
| +4% | +$37.1K | ﹤0.01% | 3347 |
|
|
2018
Q4 | $611K | Sell |
466,747
-13,616
| -3% | -$17.8K | ﹤0.01% | 3417 |
|
|
2018
Q3 | $1.18M | Buy |
480,363
+4,129
| +0.9% | +$10.1K | ﹤0.01% | 3378 |
|
|
2018
Q2 | $1.6M | Buy |
476,234
+20,621
| +5% | +$69.2K | ﹤0.01% | 3332 |
|
|
2018
Q1 | $1.93M | Buy |
455,613
+74,031
| +19% | +$313K | ﹤0.01% | 3183 |
|
|
2017
Q4 | $1.26M | Buy |
381,582
+55,695
| +17% | +$184K | ﹤0.01% | 3311 |
|
|
2017
Q3 | $1.25M | Buy |
325,887
+25,024
| +8% | +$95.7K | ﹤0.01% | 3332 |
|
|
2017
Q2 | $1.32M | Buy |
+300,863
| New | +$1.32M | ﹤0.01% | 3274 |
|